Articles Posted in Mass Torts

This page is about social media addiction lawsuits and who is eligible to bring a claim. Our lawyers also provide the latest news on social media class action lawsuits (including the ongoing trial in California).

The problem that led to social media lawsuits is that millions of people, too many of whom are children, are addicted to social media platforms such as Facebook, Instagram, Snapchat, and others. For these vulnerable users, social media addiction can be very harmful and lead to things like eating disorders, depression, and, in some cases, suicide.

Now, these companies are facing a wave of new social media lawsuits alleging that they knowingly designed the algorithms of their platforms to lure young people into harmful addictions.

Our lawyers are handling Paragard IUD lawsuits for women throughout the United States. These cases allege that the copper IUD can fracture during removal, leaving one or both plastic arms inside the uterus and sometimes forcing the patient to undergo another procedure or surgery.

The federal litigation now includes more than 4,000 filed cases. The first bellwether trial ended in a defense verdict in February 2026. That was a real loss for plaintiffs, and it changed the settlement calculus maybe a bit. But it is just one case, and all that can be turned around with a win in September 2026 when we have the next trial.

So there is no Paragard settlement deal as of August 2026. Our lawyers still believe these claims may eventually be resolved through a negotiated settlement, but the first defense verdict makes it harder to predict when that could happen or what defendants will be willing to pay. We discuss our estimated Paragard settlement values below.

This page is about Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

This page is for women considering filing a Depo-Provera lawsuit. Our lawyers provide the latest updates, explain the litigation and settlement process, and offer our assessment of potential Depo-Provera settlement amounts.

Scientific research has found a strong association between prolonged use of injectable medroxyprogesterone acetate, the active drug in Depo-Provera, and intracranial meningioma. Women who received Depo-Provera injections and were later diagnosed with a meningioma are filing lawsuits alleging that Pfizer and related companies failed to provide an adequate warning.

Our attorneys are reviewing these cases nationwide. If you believe you may have a Depo-Provera claim, call us at 800-553-8082 or contact us online.

Currently, thousands of hernia mesh lawsuits are pending in courts across the country. Our hernia mesh lawyers are handling these cases in all 50 states. This page:

  1. Discusses this litigation
  2. Provides the latest 2026 updates and the latest hernia mesh Bard MDL-2846 news on the settlement

This page provides updates on Camp Lejeune lawsuits. Our lawyers are still working to give the latest update on the litigation, even though we are no longer taking new cases. Why? Because there is little information out there, and we are staying with victims, including those we do not represent, until the end.

We have also recently reopened the comments below to answer any questions you may have or simply give you a chance to share your thoughts.

Latest Camp Lejeune Lawsuit Updates for 2026

Our lawyers are handling Taxotere eye injury lawsuits throughout the United States for women with permanently watery eyes from docetaxel.

Taxotere (docetaxel) is a widely used breast cancer chemotherapy drug. New evidence has emerged showing that Taxotere may be causing some users to suffer permanent vision loss or damage.

This has led to a wave of product liability Taxotere lawsuits by women who claim that Taxotere damaged their eyesight. The manufacturer of Taxotere, Sanofi, allegedly knew about the risk of vision damage but chose not to warn doctors or patients about this risk.

Women are still filing vaginal mesh lawsuits and bladder sling lawsuits in 2026, but this is no longer the enormous federal mass tort it was a decade ago. The old federal MDLs have closed. Most legacy claims have been resolved, and the remaining litigation is concentrated in individual cases and state-court dockets, including active Johnson & Johnson and Ethicon pelvic mesh cases in New Jersey.

A viable case now depends less on the history of the prior litigation and more on specific evidence: the manufacturer and product, the date of implantation, mesh erosion or another documented complication, revision surgery, and medical evidence linking the implant to the injury. Our lawyers are currently focused on selected claims involving products from Johnson & Johnson/Ethicon and Coloplast. We are not accepting new Boston Scientific mesh claims.

Substantively updated: July 30, 2026

Bard PowerPort lawsuits allege that defects in implanted port catheters can cause fractures, migration, blood clots, infections, embolisms, and other serious complications. Thousands of product liability lawsuits are now pending against Bard and its parent company, Becton Dickinson, in a federal multidistrict litigation in Arizona.

The first bellwether trial ended with a partial defense verdict and a deadlocked jury on the central design defect claim. The next trial, Divelbliss v. C.R. Bard, is scheduled to begin on August 18, 2026. It involves an alleged fracture of a silicone Groshong catheter. Five bellwether trials are now expected to run through February 2027. Our lawyers remain bullish on well-documented fracture, migration, and embolization cases. Infection-only claims may face harder causation arguments and could receive lower settlement offers if Bard eventually proposes a global resolution.

This page provides the latest Bard PowerPort lawsuit updates, projected settlement amounts, and information about who may qualify to file a claim. No global settlement has been announced, and all payout estimates remain speculative.

A spinal cord stimulator is an implantable medical device used to manage chronic pain, most often involving the back or spine. These systems are marketed as a way to reduce pain by interrupting nerve signals before they reach the brain. But for a growing number of patients, the device fails to help. It introduces new and sometimes permanent problems, including electrical shocks, burning pain, infections, lead migration, hardware failure, and repeat surgeries to reposition or remove equipment that was supposed to improve quality of life.

This page explains spinal cord stimulator lawsuits and why they are being filed nationwide. It focuses on what patients are alleging, how these devices have failed in real-world use, and why many of these cases go beyond ordinary medical malpractice claims. The most serious lawsuits do not center on a single surgical mistake. They examine how modern spinal cord stimulators were designed, tested, and approved, and whether patients were ever adequately warned about the risks that now recur repeatedly in medical records and FDA reports.

Many people arrive here with a practical question in mind: what do spinal cord stimulator settlement amounts look like, and how does compensation get calculated when a device causes lasting harm? That question cannot be answered in isolation. Settlement amounts and payouts are driven by the full medical timeline, including the costs of repeat surgeries, explantation, and permanent loss of function, as well as the downstream consequences when a pain-management device leaves someone worse off than before it was implanted.

Contact Information